Literature DB >> 15350223

Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.

Marcel A T M van Vugt1, Alexandra Brás, René H Medema.   

Abstract

DNA damage triggers multiple checkpoint pathways to arrest cell cycle progression. Less is known about the mechanisms that allow resumption of the cell cycle once checkpoint signaling is silenced. Here we show that while in undamaged cells several redundant pathways can promote the onset of mitosis, this redundancy is lost in cells recovering from a DNA damage-induced arrest. We demonstrate that Plk1 is crucial for mitotic entry following recovery from DNA damage. However, Plk1 is no longer required in cells depleted of Wee1, and we could show that Plk1 is involved in the degradation of Wee1 at the onset of mitosis. Thus, our data show that the cell cycle machinery is reset in response to DNA damage and that cells become critically dependent on Plk1-mediated degradation of Wee1 for their recovery. Copyright 2004 Cell Press

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15350223     DOI: 10.1016/j.molcel.2004.07.015

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  165 in total

Review 1.  Prophase I arrest and progression to metaphase I in mouse oocytes: comparison of resumption of meiosis and recovery from G2-arrest in somatic cells.

Authors:  Petr Solc; Richard M Schultz; Jan Motlik
Journal:  Mol Hum Reprod       Date:  2010-05-07       Impact factor: 4.025

Review 2.  What goes on must come off: phosphatases gate-crash the DNA damage response.

Authors:  Dong-Hyun Lee; Dipanjan Chowdhury
Journal:  Trends Biochem Sci       Date:  2011-09-18       Impact factor: 13.807

3.  Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress.

Authors:  Liyong Zhang; Chi-Hoon Park; Jing Wu; Hyun Kim; Weijun Liu; Takeo Fujita; Manimalha Balasubramani; Emanuel M Schreiber; Xiao-Fan Wang; Yong Wan
Journal:  EMBO J       Date:  2010-04-27       Impact factor: 11.598

4.  Recovery from a DNA-damage-induced G2 arrest requires Cdk-dependent activation of FoxM1.

Authors:  Mónica Alvarez-Fernández; Vincentius A Halim; Lenno Krenning; Melinda Aprelia; Shabaz Mohammed; Albert J Heck; René H Medema
Journal:  EMBO Rep       Date:  2010-04-09       Impact factor: 8.807

Review 5.  Recent Advances and New Strategies in Targeting Plk1 for Anticancer Therapy.

Authors:  Kyung S Lee; Terrence R Burke; Jung-Eun Park; Jeong K Bang; Eunhye Lee
Journal:  Trends Pharmacol Sci       Date:  2015-10-17       Impact factor: 14.819

6.  MCPH1 is essential for cellular adaptation to the G2-phase decatenation checkpoint.

Authors:  María Arroyo; Ryoko Kuriyama; Israel Guerrero; Daniel Keifenheim; Ana Cañuelo; Jesús Calahorra; Antonio Sánchez; Duncan J Clarke; J Alberto Marchal
Journal:  FASEB J       Date:  2019-04-09       Impact factor: 5.191

7.  Plk1 Phosphorylation of Mre11 Antagonizes the DNA Damage Response.

Authors:  Zhiguo Li; Jie Li; Yifan Kong; Shan Yan; Nihal Ahmad; Xiaoqi Liu
Journal:  Cancer Res       Date:  2017-05-16       Impact factor: 12.701

Review 8.  In vivo roles of CDC25 phosphatases: biological insight into the anti-cancer therapeutic targets.

Authors:  Hiroaki Kiyokawa; Dipankar Ray
Journal:  Anticancer Agents Med Chem       Date:  2008-12       Impact factor: 2.505

9.  Plk1-Mediated Phosphorylation of TSC1 Enhances the Efficacy of Rapamycin.

Authors:  Zhiguo Li; Yifan Kong; Longzhen Song; Qian Luo; Jinghui Liu; Chen Shao; Xianzeng Hou; Xiaoqi Liu
Journal:  Cancer Res       Date:  2018-03-20       Impact factor: 12.701

10.  Regulation of polo-like kinase 1 by DNA damage and PP2A/B55α.

Authors:  Ling Wang; Qingyuan Guo; Laura A Fisher; Dongxu Liu; Aimin Peng
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.